Peter Hoskin

Peter Hoskin

UNVERIFIED PROFILE

Are you Peter Hoskin?   Register this Author

Register author
Peter Hoskin

Peter Hoskin

Publications by authors named "Peter Hoskin"

Are you Peter Hoskin?   Register this Author

100Publications

2565Reads

23Profile Views

External beam radiotherapy (EBRT) and high-dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: the impact of EBRT volume.

Int J Radiat Oncol Biol Phys 2019 Oct 11. Epub 2019 Oct 11.

Mount Vernon Cancer Centre, Northwood, UK; University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.09.044DOI Listing
October 2019

Organ preservation in bladder cancer: an opportunity for truly personalized treatment.

Nat Rev Urol 2019 Sep 13;16(9):511-522. Epub 2019 Jun 13.

Manchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0199-xDOI Listing
September 2019

New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer.

Nat Rev Urol 2019 Sep 25;16(9):523-538. Epub 2019 Jul 25.

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0213-3DOI Listing
September 2019

Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb).

Radiother Oncol 2019 Aug 3;137:38-44. Epub 2019 May 3.

Mount Vernon Cancer Centre, Northwood, United Kingdom; University of Manchester, Manchester, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.04.019DOI Listing
August 2019

Single Fraction High-Dose-Rate Brachytherapy: Too Good to Be True?

Int J Radiat Oncol Biol Phys 2019 Aug;104(5):1054-1056

Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.04.036DOI Listing
August 2019

Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis.

Radiother Oncol 2019 Aug 21. Epub 2019 Aug 21.

London Regional Cancer Program, London Health Sciences Centre, University of Western Ontario, London, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.06.037DOI Listing
August 2019

Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.

Eur Urol 2019 Jul 4;76(1):69-70. Epub 2019 Feb 4.

Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.01.040DOI Listing
July 2019

Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.

Radiother Oncol 2018 12 2;129(3):499-506. Epub 2018 Jun 2.

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140183028
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2018.05.022DOI Listing
December 2018

Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.

Brachytherapy 2018 Jan - Feb;17(1):181-186. Epub 2017 Nov 15.

Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2017.09.012DOI Listing
July 2018

Clinical trials targeting hypoxia.

Br J Radiol 2018 Jul 6:20170966. Epub 2018 Jul 6.

1 Mount Vernon Cancer Centre , Northwood , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20170966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435072PMC
July 2018

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

EBioMedicine 2018 May 23;31:182-189. Epub 2018 Apr 23.

Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester M20 4BX, UK; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.04.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014579PMC
May 2018

Bladder cancer and the National Cancer Data Base: New insight or misinformation?

Cancer 2018 03 16;124(6):1105-1107. Epub 2018 Jan 16.

Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31210DOI Listing
March 2018

The optimism surrounding stereotactic body radiation therapy and immunomodulation.

Chin Clin Oncol 2017 Sep;6(Suppl 2):S9

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2017.05.01DOI Listing
September 2017

Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.

Am J Clin Oncol 2017 Aug;40(4):418-422

*Department of Radiation Oncology, Duke University Medical Center, Durham, NC †Princess Alexandra Hospital, Brisbane, Qld, Australia ‡Department of Radiation Oncology, St. Luke's International Hospital, Akashicho, Chuouku, Tokyo, Japan §London Health Sciences Centre, London, ON, Canada ∥Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH ¶Mount Vernon Cancer Centre, Northwood, UK #Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA **Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000169DOI Listing
August 2017

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.

Clin Cancer Res 2017 Aug 11;23(16):4761-4768. Epub 2017 Apr 11.

Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0038DOI Listing
August 2017

The dosimetric impact of air in vaginal vault brachytherapy.

Brachytherapy 2016 Nov - Dec;15(6):832-838. Epub 2016 Sep 29.

Cancer Centre, Mount Vernon Hospital, Middlesex, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2016.08.006DOI Listing
July 2017

How should radiation oncologists interpret the ASTRO evidence-based guideline and ASTRO Choosing Wisely campaign for the treatment of uncomplicated bone metastases?

Pract Radiat Oncol 2017 Jan - Feb;7(1):13-15. Epub 2016 Sep 29.

Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2016.09.008DOI Listing
July 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Treat All Known Disease.

Authors:
Peter J Hoskin

Int J Radiat Oncol Biol Phys 2017 07;98(3):494

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.12.006DOI Listing
July 2017

Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer.

Radiother Oncol 2017 07 27;124(1):56-60. Epub 2017 Jun 27.

Mount Vernon Hospital, Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.06.014DOI Listing
July 2017

The evolution of brachytherapy for prostate cancer.

Nat Rev Urol 2017 Jun;14(7):415-439

Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2017.76DOI Listing
June 2017

Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis.

Ann Palliat Med 2017 Apr 9;6(2):125-142. Epub 2017 Jan 9.

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/apm.2016.12.04DOI Listing
April 2017

Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review.

Radiother Oncol 2017 03 12;122(3):323-331. Epub 2017 Jan 12.

Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.12.031DOI Listing
March 2017

Hypoxia dose painting in prostate and cervix cancer.

Authors:
Peter J Hoskin

Acta Oncol 2015 6;54(9):1259-62. Epub 2015 Jul 6.

a Mount Vernon Cancer Centre , Northwood , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1061692DOI Listing
August 2016

Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.

Radiother Oncol 2016 08 29;120(2):293-9. Epub 2016 Jun 29.

Departments of Radiotherapy and Medical Physics, St James's Institute of Oncology, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.05.026DOI Listing
August 2016

Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Nat Rev Clin Oncol 2016 07 27;13(7):447-59. Epub 2016 Jan 27.

Department of Clinical Oncology, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Rickmansworth road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.218DOI Listing
July 2016

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.

Prostate 2016 07 23;76(10):905-16. Epub 2016 Mar 23.

Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071661PMC
July 2016

Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain.

J Clin Oncol 2016 Feb 7;34(6):550-6. Epub 2015 Dec 7.

Marie Fallon and Barry J.A. Laird, Edinburgh Cancer Research Centre, University of Edinburgh; Lesley A. Colvin, Western General Hospital and University of Edinburgh; Susan M. Fleetwood-Walker, School of Biomedical Sciences, University of Edinburgh; Gordon D. Murray, Centre for Population Health Sciences, University of Edinburgh, Edinburgh; Peter J. Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, and University College London; Douglas Adamson, Princess Alexandra Centre, Ninewells Hospital, Dundee; Anthony Byrne, Marie Curie Palliative Care Research Centre, Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom; and Barry J.A. Laird, European Palliative Care Research Centre, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098845PMC
February 2016

A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.

Radiother Oncol 2016 Jan 5;118(1):122-30. Epub 2015 Nov 5.

Mount Vernon Cancer Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2015.10.021DOI Listing
January 2016

A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.

J Natl Cancer Inst 2015 Oct 4;107(10). Epub 2015 Aug 4.

Mount Vernon Cancer Center, Northwood, UK (PH); Nottingham University Hospitals NHS Trust, Nottingham, UK (SS); Cancer Research UK & UCL Cancer Trials Center, London, UK (KR, SF, AK MJ, AH); Kent & Canterbury Hospital, Canterbury, UK (NM); Essex County Hospital, Colchester, UK (BS); Royal Sussex County Hospital, Brighton, UK (DB); Scunthorpe General Hospital, Scunthorpe, UK (SU); Bristol Haematology & Oncology Center, Bristol, UK (PW); CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK (MS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv197DOI Listing
October 2015

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

N Engl J Med 2015 Apr;372(17):1598-607

From the Institute of Cancer Sciences, University of Manchester, and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester (J.R., T.I.), Cancer Research UK and University College London Cancer Trials Centre, Cancer Institute, University College London (N.C., B.P., P.S.), St. Georges Hospital, University of London (R.P.), St. Bartholomew's Hospital (A.L.), and the PET Imaging Centre, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital (M.O., S.B.), London, the University of Sheffield and Weston Park Hospital, Sheffield (B.H.), Cancer Research UK Centre, Southampton (P.J.), Norfolk and Norwich University Hospital, Norwich (J.W.), Aberdeen Royal Infirmary, Aberdeen (D.C.), Nottingham City Hospital, Nottingham (A.M.), Queen's Hospital, Romford (A.B.), Royal Cornwall Hospital NHS Trust, Truro (A.K.), and the Cancer Centre, Mount Vernon Hospital, Northwood (P.H.) - all in the United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1408648DOI Listing
April 2015

International survey of the treatment of metastatic spinal cord compression.

J Radiosurg SBRT 2015 ;3(3):237-245

Department of Radiation Oncology Mater Centre, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746338PMC
January 2015

Cancer induced bone pain.

BMJ 2015 Jan 29;350:h315. Epub 2015 Jan 29.

Academic Unit of Palliative Care, Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://www.bmj.com/cgi/doi/10.1136/bmj.h315
Publisher Site
http://dx.doi.org/10.1136/bmj.h315DOI Listing
January 2015

Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.

J Clin Oncol 2014 Dec 27;32(34):3867-73. Epub 2014 Oct 27.

Edward Chow, Sunnybrook Odette Cancer Centre, University of Toronto; Rebecca K.S. Wong, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto; Ralph M. Meyer, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton; Bingshu E. Chen, Carolyn F. Wilson, and Michael Brundage, Cancer Research Institute, Queen's University, Kingston, Ontario; Jackson S.Y. Wu, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta; Abdenour Nabid, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; Yvette M. van der Linden, Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden; Caroline J.A. Tissing-Tan, Institute for Radiation Oncology Arnhem, Arnhem; Bing Oei, Dr Bernard Verbeeten Instituut, Tilburg, the Netherlands; Daniel Roos, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia; William F. Hartsell, Central DuPage Hospital Cancer Center, Warrenville, IL; Peter Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom; Scott Babington, Christchurch Hospital, Christchurch, New Zealand; and William F. Demas, Akron City Hospital, Northeast Ohio Medical University, Akron, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239305PMC
December 2014

Protons and more: state of the art in radiotherapy.

Clin Med (Lond) 2014 Dec;14 Suppl 6:s61-5

Mount Vernon Cancer Centre, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7861/clinmedicine.14-6-s61DOI Listing
December 2014

Risk of premature menopause after treatment for Hodgkin's lymphoma.

J Natl Cancer Inst 2014 Sep 19;106(9). Epub 2014 Aug 19.

Divisions of Genetics and Epidemiology (AJS, RC), Breast Cancer Research (AJS) and Radiotherapy (AH), Institute of Cancer Research, Sutton, UK; University of Manchester and Christie NHS Foundation Trust, Manchester, UK (JR); Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK (DC); Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK (IS); Cancer Research UK Medical Oncology Unit, St. Bartholomew's Hospital, London, UK (TAL); Cancer Centre, Mount Vernon Hospital, Middlesex, UK (PJH); St. James Institute of Oncology, Leeds, UK (DG); Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK (HHL); Bristol Haematology and Oncology Centre, Bristol, UK (SJF); Addenbrooke's Hospital, Cambridge, UK (MVW); Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK (BWH); Guy's and St. Thomas, London, UK (SJH); Department of Haematology, University College Hospital, London, UK (DCL); Southampton General Hospital, Southampton, UK (AB); Queen Elizabeth Hospital, Birmingham, UK (AMS). The England and Wales Hodgkin Lymphoma Follow-up Group includes the authors of this article plus: Gabriel Anghel, Lincoln Hospital; Brian Attock, North Devon District Hospital; Jane Barrett, Royal Berkshire Hospital; Andrew Bell, Poole Hospital; Kim Benstead, Cheltenham General Hospital; Eric M. Bessell, Nottingham University Hospital; Ashoke Biswas, Royal Preston Hospital; Norbert Blesing, Great Western Hospital, Swindon; Caroline Brammer, New Cross Hospital, Wolverhampton; Jill Brock, Clatterbridge Centre for Oncology; Alison Brownell, Queens Hospital, Romford; A. Murray Brunt, University Hospital of North Staffordshire; Peter B. Coates, Queen Elizabeth Hospital, King's Lynn; Matthew P. Collinson, Royal Cornwall Hospital; Neville Davidson, Essex County Hospital; Sian Davies, North Middlesex University Hospital; Ian Fentiman, Guy's Hospital; Eve Gallop-Evans, Velindre Hospital; Angel Garcia, Glan Clwyd Hospital; Andrew Goodman, Royal Devon and Exeter Hospital; Ad

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju207DOI Listing
September 2014

Guidelines for the first line management of classical Hodgkin lymphoma.

Br J Haematol 2014 Jul 9;166(1):34-49. Epub 2014 Apr 9.

Department of Haematology, Addenbrookes Hospital, Cambridge University Teaching Hospitals, Cambridge, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12878
Publisher Site
http://dx.doi.org/10.1111/bjh.12878DOI Listing
July 2014

High-dose-rate brachytherapy with two or three fractions as monotherapy in the treatment of locally advanced prostate cancer.

Radiother Oncol 2014 Jul 10;112(1):63-7. Epub 2014 Jul 10.

Cancer Centre, Mount Vernon Hospital, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2014.06.007DOI Listing
July 2014

Overall response rates to radiation therapy for patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment.

Radiother Oncol 2014 Jul 11;112(1):125-7. Epub 2014 Jul 11.

Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140140028
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2014.06.015DOI Listing
July 2014

Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.

BJU Int 2014 May 2;113(5):748-53. Epub 2013 Dec 2.

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12358DOI Listing
May 2014

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity.

Radiother Oncol 2014 Feb 11;110(2):268-71. Epub 2013 Nov 11.

Cancer Centre, Mount Vernon Hospital, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.09.025DOI Listing
February 2014

Re-irradiation for painful bone metastases - a systematic review.

Radiother Oncol 2014 Jan 3;110(1):61-70. Epub 2013 Oct 3.

Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140130046
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2013.09.004DOI Listing
January 2014

The influence of prostate volume on outcome after high-dose-rate brachytherapy alone for localized prostate cancer.

Int J Radiat Oncol Biol Phys 2013 Oct 9;87(2):270-4. Epub 2013 Jul 9.

Mount Vernon Cancer Centre, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.05.022DOI Listing
October 2013

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.

Radiother Oncol 2013 Jul 14;108(1):40-7. Epub 2013 Jun 14.

Translational Radiobiology Group, Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Centre, Christie Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.05.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885794PMC
July 2013

Second primary cancers after radiation for prostate cancer: a review of data from planning studies.

Radiat Oncol 2013 Jul 8;8:172. Epub 2013 Jul 8.

St James's Institute of Oncology, Beckett St, Leeds LS9 7TF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1748-717X-8-172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724744PMC
July 2013

Critical structure movement in cervix brachytherapy.

Radiother Oncol 2013 Apr 22;107(1):39-45. Epub 2013 Feb 22.

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.01.006DOI Listing
April 2013

Targeted radio-nuclide therapy of skeletal metastases.

Cancer Treat Rev 2013 Feb 24;39(1):18-26. Epub 2012 Apr 24.

Dept. of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.03.006DOI Listing
February 2013

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder.

J Biophotonics 2013 Jan 2;6(1):73-87. Epub 2012 Nov 2.

Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201200126DOI Listing
January 2013

Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.

Radiology 2013 Jan 20;266(1):326-36. Epub 2012 Nov 20.

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.12112428DOI Listing
January 2013

Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.

Radiother Oncol 2012 Aug 31;104(2):192-8. Epub 2012 Jul 31.

University Hospital Gasthuisberg, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2012.06.014DOI Listing
August 2012

Bladder conservation for muscle-invasive bladder cancer.

Expert Rev Anticancer Ther 2012 Aug;12(8):1015-20

Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.79DOI Listing
August 2012